Investor Presentaiton slide image

Investor Presentaiton

Comprehensive and competitive meningococcal portfolio provides new source of growth 77 Vaccines Investor Event MenQuadfi Best-in-Class MenACWY vaccine MenB formulation demonstrates strong potential for cross-protection across B strains Advancing MenPenta development in ready-to-use syringe with expected U.S. submission in 2027 sanofi
View entire presentation